🇺🇸 FDA

Drug profile · INN

sodium phosphate, dibasic, anhydrous

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

sodium phosphate, dibasic, anhydrous (MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sodium phosphate, dibasic, anhydrous
Brand MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
Route ORAL
Formulation TABLET

Frequently asked questions

What is sodium phosphate, dibasic, anhydrous?

sodium phosphate, dibasic, anhydrous (MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sodium phosphate, dibasic, anhydrous?

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE is a marketed brand name for sodium phosphate, dibasic, anhydrous. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium phosphate, dibasic, anhydrous?

sodium phosphate, dibasic, anhydrous has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.